# R041 — Harnessing Artificial Intelligence to Predict Ovarian Stimulation Outcomes in In Vitro Fertilization: Scoping Review

**AlSaad, Abd-alrazaq, Choucair et al. (2024).** *Journal of Medical Internet Research*. DOI: [10.2196/53396](https://doi.org/10.2196/53396)

**Role:** contextual · workflow: n/a

**Cited in:** Introduction, Computational methods

**PDF:** not mirrored - see DOI | **Interactive card:** [card.html](card.html)

## Manuscript passages citing this work
> **§ Introduction**
> ==Specialized reviews supply complementary technical and evaluative foundations. Earlier accounts examine ART prediction, laboratory algorithm selection, visual tasks, hardware and workflows [@ER001,ER003,ER002,ER005]. Microscopy, andrology, time-lapse and governance perspectives clarify acquisition conditions and implementation context, including distinctions between human and animal evidence or stained and live cells [@ER009,ER014,ER010,ER015]. Focused syntheses compare AI with embryologists, examine ploidy prediction, map time-lapse deep learning, and assess stimulation prediction, sperm selection and semen analysis [@R019,R024,R025,R032,R039,R041]. Ranking, probability estimation, calibration, explainability and implementation readiness likewise have substantial precedents [@R016,R030,R049]. Together, these accounts establish the clinical coverage and major evaluation concerns. Our focus is the relationship between them: how a computational mechanism acts on available observations, what its supervision identifies and which comparison can establish its contribution.==

> **§ Introduction**
> ==The comparison schema builds on existing evidence tables. Gao and colleagues' Table S1 records modality, input, stage, task, performance, sample and study [@R012]. Ouyang and Wei group methods by shared datasets and tabulate public resources; Lorimer and colleagues connect model inputs to predicted outcomes; Hu and colleagues record stage, device, inputs, sample size and validation [@R028,R014,R015]. We link those study descriptors to result-specific input-availability cutoffs, biological units, partitions, calibration and documented cohort relationships. Focused reviews supply complementary validation criteria [@R025,R041,R016]. The resulting records distinguish reuse of a named resource from reuse of participants or a held-out partition, and separate a richer input set from a change in the computational mechanism. These distinctions turn a performance catalogue into an explanation of what each comparison establishes.==

> **§ Computational methods** : Fixed-vector representations: clinical records and structured measurements
> ==12 A fixed vector records measurements available at a decision. Patient characteristics, treatment histories, laboratory measurements and embryo summaries support tabular learning across ART personalization and stimulation. Spatial arrangement, temporal order and biological membership enter through supplied features [@R005,R006,R041].==

> **§ Computational methods** : Fixed-vector representations: clinical records and structured measurements
> ==Let $ I_i(t)$ denote the information available for case $i$ at decision time $t$. A tabular predictor is $ y_i,t=f_ ( ( I_i(t)))$: $ $ constructs the vector and $f_ $ learns its relation to a target. Moving from pretreatment counseling to post-retrieval prognosis changes the information set and eligible population, even if the estimator stays fixed. Timing restrictions in stimulation reviews and temporal-representation distinctions in longitudinal reviews support separating these choices [@R041,R045].==

> **§ Computational methods** : Nonlinear estimators and response targets
> ==The target's mathematical structure determines the learning objective. Binary response classes, oocyte counts and dose-normalized transformations use different losses and scales. An externally evaluated XGBoost framework separates baseline response-risk models from models encoding a planned stimulation regimen; enumerated regimens yield conditional predictions for the observed treatment setting. Another two-center study predicts the logarithm of retrieved-oocyte count divided by starting FSH dose alongside early OHSS risk. Its regression errors are on that transformed scale, and discrepancies among its threshold metrics remain unresolved. These examples connect target transformation and predictor timing to performance interpretation [@EC031,EC032,R041,R042].==

> **§ Computational methods** : Trajectory summaries and recorded-action learning
> ==Treatment variables encode patient state and clinical choice. The quantity $ E[Y A=a,X=x]$ describes an observed conditional relationship; a recommendation concerns the consequence of assigning $a$. Attribution and input perturbation characterize the fitted mapping, while assignment-aware estimation addresses the intervention. Prognosis, imitation and policy evaluation therefore retain distinct objectives even when their columns and estimators coincide [@R005,R041,R042,R030,R048].==

---
*Machine-extracted; human verification pending. == ... == marks supporting content.*